Semaglutide trials for Type 2 diabetes

All Semaglutide trials · All Type 2 diabetes trials

Phase breakdown

Recruiting trials studying Semaglutide for Type 2 diabetes

• A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
  NCT06717698 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 147 locations
• A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes
  NCT07415954 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 63 locations
• A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
  NCT07668388 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 70 locations
• A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
  NCT07564414 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 303 locations
• A Study of BGM0504 in Early T2DM With Obesity
  NCT07743983 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• A Study of BGM0504 in Participants With Type 2 Diabetes in Indonesia
  NCT07064486 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 4 locations
• A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
  NCT07662213 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 209 locations
• GLP1-RAs Effects on Inflammatory and Endothelial Biomarkers in T2DM
  NCT07314684 · Phase: Phase 4 · Ages: 18 Years to 85 Years · Sex: All (male and female) · 2 locations
• Investigating the Impact of GLP-1 RA Therapy on Osteosarcopenia in Older Female Adults With Diabetes
  NCT07428746 · Phase: Phase 3 · Ages: 65 Years and older · Sex: Female · 1 location
• Semaglutide for Smoking Cessation in Patients With Diabetes
  NCT07059377 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Side-to-Side Duodeno-ileostomy Versus Semaglutide in Adults With Obesity and Type 2 Diabetes
  NCT07317115 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Study of Adult Patients Residing in Argentina Diagnosed With Type 2 Diabetes Treated With a New Formulation of Semaglutide, Both Oral and Subcutaneous, in a Real-world Setting at 3 Months, 6 Months, and 1 Year of Follow-up, Quantifying the Reduction in Glycated Hemoglobin
  NCT07621419 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 4 locations
• The Impact of Semaglutide Compared to Energy Restriction on Type 2 Diabetes
  NCT07272343 · Phase: Phase 4 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location

Common questions

How many trials study Semaglutide for Type 2 diabetes?

13 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.